It is a pharma public limited company based in Chennai - 600 042., Tamil Nadu, India, established in 2002.
2002 | Chennai - 600 042., Tamil Nadu, India | ActiveCitadel Aurobindo Biotech Limited, a active public limited company, was established on 22 March 2002 in Chennai - 600 042., Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the hospital and medical care sector, it holds CIN: U24231TN2002PLC048652. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.
It upholds a active non-compliant status. Its leadership includes Mruthyunjaya Reddy Kapuluru (Director), Rajiv Krishnamurthy (Director), Sardar Sulakshan Singh (Director). Past directors included Ramkumar Krishnamurthy Anekar, Sadananda Reddy Sannareddy, Padmanoor Harihara Rao Rajendra Rao. It holds no open charges and ₹40.00 Cr settled loans. Its latest AGM occurred on 05 September 2020, with the balance sheet filed on 31 March 2019. It is based at 43, Main Road,Velacherry, Velacherry,, Chennai - 600 042., Tamil Nadu, 600042.
U24231TN2002PLC048652
048652
22 March 2002
₹2.00 Cr
₹2.00 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Citadel Aurobindo Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mruthyunjaya Reddy Kapuluru | Director | 15 Apr 2002 | Current |
| Rajiv Krishnamurthy | Director | 06 Feb 2007 | Current |
| Sardar Sulakshan Singh | Director | 04 Dec 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Nominee Director | 16 Sep 2006 | Past |
| Pramod Abcsdd | Director | 30 Mar 2007 | Past |
| Pramod Abcsdd | Nominee Director | 25 Jan 2007 | Past |
| Pramod Abcsdd | Nominee Director | 12 Sep 2006 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Citadel Aurobindo Biotech Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 44.42% decrease. The company also saw a substantial fall in profitability, with a 9583.74% decrease in profit. The company's net worth dipped by a decrease of 0.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Citadel Aurobindo Biotech had a public holding of 100.00%. The company had 3 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹400,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jan 2003 | Uti Bank Limited | ₹30.00 Cr | Satisfied |
| 21 Oct 2002 | Standard Chartered Bank | ₹10.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Citadel Aurobindo Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Citadel Aurobindo Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Citadel Aurobindo Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Citadel Aurobindo Biotech Limited last Annual general meeting of members was held on 05 Sep 2020 as per latest MCA records. was completed.
The activity Citadel Aurobindo Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Chennai. was completed.
Rajiv Krishnamurthy was appointed as a Director was appointed as a Director on 06 Feb 2007 & has been associated with this company since 18 years 9 months . was recorded as a recent event.
Progress on A charge registered on 24 Jan 2003 via Charge ID 90293101 with Uti Bank Limited was fully satisfied on 11 Dec 2006. was documented.
Sardar Sulakshan Singh was appointed as a Director was appointed as a Director on 04 Dec 2006 & has been associated with this company since 18 years 11 months . was recorded as a recent event.
A charge registered on 21 Oct 2002 via Charge ID 90293065 with Standard Chartered Bank was fully satisfied on 31 Oct 2006. was recorded as a recent event.
The CIN of Citadel Aurobindo Biotech Limited is U24231TN2002PLC048652.
Citadel Aurobindo Biotech Limited is headquartered at 43, Main Road,Velacherry, Velacherry,, Chennai - 600 042., Tamil Nadu, 600042.
Citadel Aurobindo Biotech Limited was incorporated on 22 March 2002.
The current directors of Citadel Aurobindo Biotech Limited are
The primary industry of Citadel Aurobindo Biotech Limited is Hospital And Medical Care.
Citadel Aurobindo Biotech Limited is unlisted.
The authorized capital of Citadel Aurobindo Biotech Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.
The compliance status of Citadel Aurobindo Biotech Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX